Dactolisib outperforms Rapamycin in potentiating apoptosis induced by XPO1, Bcl-2 and Mcl-1 blockade in preclinical glioblastoma models. [PDF]
The PAM pathway and its impact on cellular metabolism. Color‐coded key symbols represent Rapamycin (R, orange, targeting mTOR) and Dactolisib (D, green, targeting PI3K/mTOR), indicating their sites of action. Created with BioRenders.com. Glioblastoma resists therapy through interconnected survival programs.
Zhao K +23 more
europepmc +4 more sources
Cancer‐Associated BCL‐2 Mutants Reveal Mechanisms Towards Venetoclax Resistance [PDF]
BCL‐2 is an anti‐apoptotic protein frequently upregulated in cancer, enabling cell survival despite oncogenic stress. This BCL‐2 dependence sensitizes tumor cells to venetoclax, an FDA‐approved drug used against chronic lymphocytic leukemia.
Jonas Aufdermauer +9 more
doaj +2 more sources
Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
Mitochondrial apoptosis is strictly controlled by BCL-2 family proteins through a subtle network of protein interactions. The tumor suppressor protein p53 triggers transcription-independent apoptosis through direct interactions with BCL-2 family proteins,
Hudie Wei +11 more
doaj +2 more sources
From Platelet Toxicity to Precision Targeting: Evolving Strategies to Overcome Thrombocytopenia in BCL‐2/BCL‐XL Inhibition [PDF]
Background Simultaneous blockade of the anti‐apoptotic proteins BCL‐2 and BCL‐XL has been shown to be efficacious in preclinical and clinical trials for tumors that are co‐dependent on their survival pathways, although clinical development has been ...
Md Mohiuddin
doaj +2 more sources
Bibi Kulsoom,1 Tahir Sultan Shamsi,1 Nasir Ali Afsar,2,3 Zahida Memon,4 Nikhat Ahmed,4 Syed Nazrul Hasnain5 1National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan; 2Jinnah Medical and Dental College, Karachi, Pakistan ...
Kulsoom B +5 more
doaj +1 more source
Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing
Background Bcl-2 is believed to contribute to melanoma chemoresistance. However, expression of Bcl-2 proteins may be different among melanomas. Thus correlations among expression of Bcl-2-related proteins and in vivo melanoma progression, and resistance ...
Mena Salvador +9 more
doaj +2 more sources
Immunohistochemical Expression of M30, BCL-2, BAX, and Ki-67 in Pancreatic Ductal Adenocarcinoma: Association with Clinicopathological Features. [PDF]
Demirciler Yavaş B, Yılmaz S.
europepmc +2 more sources
Rational structure-guided identification of a Bcl-2-targeting peptide with antiproliferative effects on colorectal cancer cells [PDF]
Jin X +5 more
europepmc +4 more sources
Gudan Wan attenuates metabolic dysfunction-associated steatohepatitis by modulating autophagy and the Bcl-2/Caspase-3/Caspase-8 apoptotic axis. [PDF]
Han S +7 more
europepmc +3 more sources
Revealing the Binding Mechanism of Gossypol on Bcl‑2 via Funnel Metadynamics Simulations [PDF]
Tao Zhu, Sheng He, Meng Luo, Wei Wang
doaj +2 more sources

